Unison agrees $526m Japan pharma carve-out
Unison Capital has agreed to buy Kyowa Pharmaceutical Industry, a Japanese subsidiary of India-headquartered drug manufacturer Lupin for an enterprise valuation of JPY57.4 billion ($526 million).
Kyowa was founded in 1954 and produces branded and generic pharmaceutical products for patients in Japan. It is the fifth-largest player in the domestic generics space, with a portfolio that includes treatments...
More on North Asia
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.